Conbercept combined with retinal photocoagulation significantly improves visual acuity and quality of life in patients with proliferative diabetic retinopathy. [PDF]
Am J Transl ResOBJECTIVE To evaluate the clinical efficacy of Conbercept combined with retinal photocoagulation in patients with proliferative diabetic retinopathy (PDR) and its effect on visual acuity and related outcomes.
Cheng Y, Wang Q, Chen L, Zhou J.
europepmc +2 more sources
Prognostic factors in the treatment of polypoidal choroidal vasculopathy with conbercept: a post hoc analysis of the STAR study. [PDF]
Eye Vis (Lond)A post hoc analysis of the STAR study, which was a 48-week, phase IV, multicenter randomized controlled multicenter clinical trial was performed. This study aims to identify the baseline factors associated with visual and anatomic changes over 48 weeks ...
Wang TI +6 more
europepmc +2 more sources
Aqueous-humor biomarkers and real-world efficacy of conbercept for diabetic macular edema: a prospective study in elderly patients. [PDF]
Front Endocrinol (Lausanne)Background To evaluate real−world efficacy of conbercept and the predictive value of aqueous−humor biomarkers in elderly diabetic macular edema (DME).
Xie M.
europepmc +2 more sources
Intravitreal conbercept injection for neovascular age-related macular degeneration [PDF]
International Journal of Ophthalmology, 2019 AIM: To evaluate the efficacy and safety of intravitreal injection of conbercept in patients with neovascular age-related macular degeneration (AMD). METHODS: Retrospective review of 66 eyes of 63 patients with neovascular AMD. All patients received 0.5
Bing-Hui Wu +4 more
doaj +3 more sources
The Efficacy of Conbercept in Polypoidal Choroidal Vasculopathy: A Systematic Review [PDF]
Journal of Ophthalmology, 2020 Topic. The aim of this study is to evaluate the efficacy of conbercept in PCV, which will optimize the management for PCV patients. Clinical Relevance. The use of antivascular endothelial growth factor (VEGF) therapy in polypoidal choroidal vasculopathy (
Yimin Wang +4 more
doaj +3 more sources
Effect of intravitreal conbercept treatment before vitrectomy in proliferative diabetic retinopathy
International Journal of Ophthalmology, 2018 To evaluate the safety and efficacy of intravitreal conbercept (IVC) injections as pretreatment for pars plana vitrectomy (PPV) in severe proliferative diabetic retinopathy (PDR).This was a retrospective chart review of all patients who underwent PPV for PDR from January 2014 to October 2016.
Jian-Bo Mao +8 more
openaire +4 more sources
Vascular endothelial growth factor/connective tissue growth factor and proteomic analysis of aqueous humor after intravitreal conbercept for proliferative diabetes retinopathy. [PDF]
Int J OphthalmolAIM To investigate the role of connective tissue growth factor (CTGF) and vascular endothelial growth factor (VEGF) in the protein profile of the aqueous humor in patients with proliferative diabetic retinopathy (PDR) following intravitreal injection of ...
Li HS +5 more
europepmc +2 more sources
Efficacy and safety of intravitreal injection of conbercept for moderate to severe nonproliferative diabetic retinopathy [PDF]
Frontiers in MedicinePurpose This study aimed to assess the effectiveness and safety of intravitreal injection of conbercept (IVC) in treating moderate to severe nonproliferative diabetic retinopathy (NPDR), with or without accompanying diabetic macular edema.
Lu Shen +9 more
semanticscholar +3 more sources
Evaluating the Efficacy of Conbercept and Dexamethasone Implants Sequentially in the Treatment of Refractory Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO): A One-Year Follow-Up Study. [PDF]
Clin OphthalmolPurpose The objective of this research was to assess the effectiveness and safety of using Conbercept injection and dexamethasone implant (DEX I) in sequence for treating refractory macular edema (ME) caused by central retinal vein occlusion (CRVO) in ...
Xing P +9 more
europepmc +2 more sources
Intravitreal ranibizumab or conbercept for retinal arterial macroaneurysm: a case series [PDF]
BMC Ophthalmology, 2019 Background There is no consensus for the standard treatment of retinal arterial macroaneurysm (RAM). Intravitreal anti-vascular endothelium growth factor (anti-VEGF) is an alternative treatment option for RAM. The purpose of this study is to describe the
Zhongjing Lin +4 more
doaj +3 more sources